Prognostic and predictive factors in pancreatic cancer | Oncotarget
Tumor M2-PK: pancreatic cancer
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology
Tumor markers in supernatant of pancreatic cancer cell lines | Download Table
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Semantic Scholar
Guidelines for the Use of Tumor Markers in Pancreatic Ductal Adenocarcinoma | Semantic Scholar
Possible Diagnostic Marker for Pancreatic Cancer - NCI
Pancreatic Cancer Tumor Markers | GeneTex
Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages | Life Science Alliance
Cellular Origins of Pancreatic Cancer – Discovery and Innovation at University of Utah Health
Detection and Diagnosis of Pancreatic Cancer
Potential Prognostic Markers for Pancreatic Cancer | Download Table
Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer - ScienceDirect
Markers of pancreatic cancer stem cells and their clinical and therapeutic implications | SpringerLink
Clinical Utility of Tumor Markers
Tumor Markers - CA153/proGRP/CA242/PGI/PGII/Cy211 | Fapon Biotech Inc.
Markers of pancreatic cancer: working toward early detection. - Abstract - Europe PMC
Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer
Oncology
Early diagnosis of pancreatic cancer: Current trends and concerns - Hanada - 2017 - Annals of Gastroenterological Surgery - Wiley Online Library
Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer - Gastroenterology
Pancreatic Cancer Tumor Markers | GeneTex
Summary of results for diagnostic pancreatic tumor markers. | Download Table
Tumor Markers in Pancreatic Cancer: 2013
